| Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile (NCT05494047) | Pontificia Universidad Catolica de Chile | 2022-07-14 |
| Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion (NCT05035680) | Gates Medical Research Institute | 2022-07-14 |
| Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP (NCT06125717) | Terrestrial Bio, Inc. | 2022-07-02 |
| Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine (NCT05027932) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-06-27 |
| A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old (NCT05375838) | ModernaTX, Inc. | 2022-05-13 |
| Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers. (NCT05284799) | Osivax | 2022-05-09 |
| Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children (NCT05315024) | The University of Hong Kong | 2022-04-30 |
| Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza (NCT05170009) | Weill Medical College of Cornell University | 2022-04-22 |
| Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older (NCT06118151) | Sanofi Pasteur, a Sanofi Company | 2022-04-11 |
| National Vaccine Adverse Event Reporting Survey and Etiology (NCT05095844) | Neuroganics LLC | 2022-03-15 |
| To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years (NCT05389137) | Wuhan Institute of Biological Products Co., Ltd | 2022-03-02 |
| A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults (NCT05252338) | CureVac | 2022-02-07 |
| A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza (NCT05160636) | Pfizer | 2022-01-31 |
| Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza (NCT05093998) | Viriom | 2022-01-15 |
| Antibiotic Therapy in Viral Airway Infections (NCT05045612) | University Hospital, Akershus | 2022-01-13 |
| InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza Infection (NCT05084846) | University Hospital, Gentofte, Copenhagen | 2022-01-01 |
| Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections (NCT05290792) | Emily McDonald | 2021-12-10 |
| A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness. (NCT05184387) | Osivax | 2021-12-01 |
| Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers. (NCT05060887) | Osivax | 2021-11-15 |
| Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine (NCT05781191) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-11-13 |
| Taxifolin/Ergothioneine and Immune Biomarkers in Healthy Volunteers (TaxEr) (NCT05190432) | University of Southampton | 2021-11-10 |
| A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months (NCT05212623) | Jiangsu Province Centers for Disease Control and Prevention | 2021-10-26 |
| Patient Portal Flu Vaccine Reminders_RCT 4 (NCT05052190) | University of California, Los Angeles | 2021-10-14 |
| Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients (NCT04712539) | M.D. Anderson Cancer Center | 2021-10-11 |
| Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting (NCT05048589) | Tor Biering-Sørensen | 2021-10-01 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections (NCT05030324) | Valenta Pharm JSC | 2021-10-01 |
| One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis. (NCT05069714) | Seoul National University Hospital | 2021-10-01 |
| Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX) (NCT05082688) | Radboud University Medical Center | 2021-09-20 |
| A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years (NCT05144464) | Jiangsu Province Centers for Disease Control and Prevention | 2021-09-19 |
| A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years (NCT05313893) | Jiangsu Province Centers for Disease Control and Prevention | 2021-09-11 |
| Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake (NCT05009251) | National Bureau of Economic Research, Inc. | 2021-09-09 |
| Lottery Incentive Nudges to Increase Influenza Vaccinations (NCT05012163) | National Bureau of Economic Research, Inc. | 2021-09-04 |
| Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects (NCT04982913) | Sunshine Lake Pharma Co., Ltd. | 2021-08-24 |
| Association Between Gut Microbiome and Dietary Determinants and Vaccine Response (NCT05239403) | M.D. Anderson Cancer Center | 2021-08-24 |
| Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain (NCT04978454) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-08-19 |
| Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination (NCT04794829) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-08-19 |
| Pharmacokinetics of Voriconazole in Adult ECMO Patients (NCT04868188) | University Hospitals, Leicester | 2021-08-10 |
| Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks (NCT05012189) | Insight Therapeutics, LLC | 2021-08-06 |
| Assessment, Feedback, Incentive, Exchange (AFIX OB) A Customizable Quality Improvement Intervention to Increase Maternal Vaccine Uptake (NCT04678271) | Yale University | 2021-07-01 |
| Comparison of ARDS COVID-19 (WHO) vs ARDS Influenza in the ICU (NCT04941092) | Central Hospital, Nancy, France | 2021-06-01 |
| First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy Adults (NCT04896086) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-05-24 |
| Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults (NCT04782323) | Seqirus | 2021-04-13 |
| Apple Respiratory Study (NCT04912180) | Apple Inc. | 2021-04-06 |
| B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults (NCT04101838) | University of Alabama at Birmingham | 2021-04-01 |
| Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine (NCT04801888) | Sinovac Research and Development Co., Ltd. | 2021-03-23 |
| Exercise and COVID-19 Viral T-cell Immunity (NCT05019456) | University of Arizona | 2021-03-09 |
| Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra (NCT05308212) | St. Petersburg Research Institute of Vaccines and Sera | 2021-03-04 |
| Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria (NCT04672577) | Patricia Schlagenhauf | 2021-01-30 |
| Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) (NCT04664075) | Imperial College London | 2021-01-25 |
| High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients (NCT04613206) | Vanderbilt University Medical Center | 2021-01-11 |
| A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza (NCT04736758) | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 2021-01-08 |
| Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD) (NCT06252051) | Universitas Padjadjaran | 2021-01-05 |
| An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older (NCT04806529) | Seqirus | 2020-12-15 |
| Pediatric Second Influenza Dose Portal Reminder Recall (NCT04668417) | University of California, Los Angeles | 2020-12-15 |
| Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness (NCT04610047) | Emergo Therapeutics, Inc. | 2020-12-14 |
| Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years (NCT05312294) | St. Petersburg Research Institute of Vaccines and Sera | 2020-12-07 |
| Maternal Determinants of Immunity to Influenza (NCT06716567) | Centre Hospitalier Universitaire Saint Pierre | 2020-11-16 |
| Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform (NCT04663776) | Boston Children's Hospital | 2020-11-04 |
| Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older (NCT04622592) | Medicago | 2020-11-02 |
| Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine (NCT04798677) | AB Biotek | 2020-10-29 |
| Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults (NCT04579250) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-10-08 |
| Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults (NCT04576702) | Seqirus | 2020-10-08 |
| Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine (NCT05869201) | St. Petersburg Research Institute of Vaccines and Sera | 2020-10-06 |
| The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata (NCT04239521) | Momentum Data | 2020-10-01 |
| Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness (NCT04570904) | University of Leicester | 2020-09-28 |
| Encouraging Flu Vaccination Among High-Risk Patients Identified by ML (NCT04323137) | Geisinger Clinic | 2020-09-21 |
| Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza (NCT06286488) | Medical University of Warsaw | 2020-09-15 |
| Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age (NCT04544267) | Sanofi Pasteur, a Sanofi Company | 2020-09-15 |
| This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam (NCT04695717) | Vietnam Military Medical University | 2020-09-05 |
| Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection (NCT04164212) | University of Alabama at Birmingham | 2020-09-01 |
| Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- UCLA Portal R/R Influenza RCT 3 (NCT04533685) | University of California, Los Angeles | 2020-09-01 |
| Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects (NCT04729764) | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 2020-08-27 |
| Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Elderly (NCT04548518) | Mahidol University | 2020-08-03 |
| A Study of HNC042 in Healthy Chinese Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics (NCT04603989) | Guangzhou Henovcom Bioscience Co. Ltd. | 2020-08-01 |
| Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants (NCT04471038) | SAb Biotherapeutics, Inc. | 2020-07-29 |
| Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South Africa (NCT05277298) | National Institute for Communicable Diseases, South Africa | 2020-07-01 |
| Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults (NCT04439695) | KBio Inc | 2020-06-25 |
| Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities (NCT04377165) | The University of Queensland | 2020-05-06 |
| Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza (NCT03903718) | MedImmune LLC | 2020-04-03 |
| Audio Data Collection for Identification and Classification of Coughing (NCT04326309) | HealthMode Inc. | 2020-03-25 |
| The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study (NCT04336020) | Scripps Translational Science Institute | 2020-03-24 |
| Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment (NCT04365608) | Lazarski University | 2020-03-20 |
| The Objectives of This Study Are Study the Immunogenicity and Safety of the Flu-M [Inactivated Split Influenza Vaccine], vs. the Ultrix® Inactivated Split Influenza Vaccine, in Volunteers Who Are Over 60 Years Old (NCT05089123) | St. Petersburg Research Institute of Vaccines and Sera | 2020-03-03 |
| Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling (NCT04282135) | Klinikum Bayreuth GmbH | 2020-02-15 |
| The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years. (NCT05317767) | St. Petersburg Research Institute of Vaccines and Sera | 2020-02-10 |
| Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (NCT04363359) | Shanghai Institute Of Biological Products | 2020-01-15 |
| Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Healthcare Workers (NCT04223544) | Wroclaw Medical University | 2020-01-13 |
| Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age (NCT04210349) | Sanofi Pasteur, a Sanofi Company | 2020-01-09 |
| Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults (NCT04250311) | Materia Medica Holding | 2019-12-12 |
| Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years (NCT04192500) | Osivax | 2019-12-11 |
| Lung Bacteriobiota and Influenza Mortality (NCT04131296) | University of Bordeaux | 2019-12-01 |
| The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy Volunteers (NCT05152017) | St. Petersburg Research Institute of Vaccines and Sera | 2019-11-16 |
| Test-and-treat for Influenza in Homeless Shelters (NCT04141917) | University of Washington | 2019-11-15 |
| Safety and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Formulations Containing Different H3 Hemagglutinin Antigens in Healthy Adult Subjects 18 to 30 Years of Age (NCT04144179) | Sanofi Pasteur, a Sanofi Company | 2019-11-06 |
| Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle (NCT04141930) | University of Washington | 2019-11-01 |
| Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel (NCT04523324) | Centers for Disease Control and Prevention | 2019-10-31 |
| Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients (NCT04143451) | The University of Hong Kong | 2019-10-23 |
| H1N1v Virus Challenge Study in Healthy Subjects (NCT04044352) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-10-22 |
| Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- RCT 2 (NCT04110314) | University of California, Los Angeles | 2019-10-18 |
| Influenza IMPRINT Cohort: Defining the Impact of Initial Influenza Exposure on Immunity in Infants (NCT05436184) | Children's Hospital Medical Center, Cincinnati | 2019-10-17 |